Genzeon Named UiPath 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences

Recognition honors a five-year partnership advancing AI-powered automation and delivering measurable results across healthcare operations

LAS VEGAS, Sept. 23, 2026 /PRNewswire/ -- Genzeon, an AI-native healthcare solutions and services company, today announced that it has been named UiPath's 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences. Presented at UiPath FUSION 2026, the award recognizes Genzeon's work helping healthcare organizations turn AI and automation into measurable operational and financial outcomes.

Through its five-year partnership with UiPath, Genzeon has helped healthcare organizations scale automation across prior authorization, referrals, claims, revenue cycle management, and other critical workflows — reducing manual work, improving accuracy, and accelerating processing.

"When our clients think about UiPath and healthcare, they think of Genzeon. Five years of joint work have made that real, from the front desk to the revenue cycle to prior authorization, across payers, providers, and life science clients. This award belongs to the teams on both sides who built it," said Harsh Singh, President, AI Business Solutions, Genzeon.

The partnership is delivering measurable results across healthcare operations. For the CMS WISeR program, Genzeon and UiPath delivered prior authorization infrastructure processing more than 450,000 cases annually across 17 high-risk service categories, automating 85% to 90% of routine determinations while meeting mandatory 72-hour turnaround requirements and FHIR and CMS-0057-F compliance.

At a leading pediatric health system, a UiPath-powered referral workflow developed by Genzeon reduced processing time from approximately six minutes to less than one minute, saving an estimated 2,250 staff hours each month.

For a national complex rehabilitation provider, Genzeon and UiPath expanded automated prior authorization coverage from four payers to more than 100, reducing manual touches by 70% to 80% and errors by 90% to 95% during the first phase.

Across the broader partnership, Genzeon has deployed more than 45 AI agents into production and delivered more than 5,000 healthcare automation components.

"ROI is not decided at go-live — it is decided six months into production, when that claim is still getting paid and that referral is still closing the same day," said Vinit Singhal, Sales Leader, AI Business Solutions, Genzeon. "We run Business Value Prioritization before we build and AI Realization after it ships, because day two is where the value actually shows up."

"I'm thrilled to congratulate Genzeon on its recognition as a 2026 UiPath Partner of the Year," said Ashim Gupta, CFO/COO at UiPath. "Genzeon plays a crucial role in helping customers transform how people, robots and agents work together to achieve full value of their AI investments and deliver real enterprise impact."

Genzeon is a UiPath Platinum Partner with a dedicated healthcare-focused UiPath business unit supporting solution development, go-to-market initiatives, professional services, and continued innovation.

To learn more, visit www.genzeon.com.

About Genzeon

Genzeon is an AI-native healthcare solutions and services company delivering AI solutions for payers, providers, and life sciences organizations through deep domain expertise, engineering, data capabilities, and purpose-built platforms.

Media Contact
Bianca Beatty
Genzeon
[email protected] 
239-961-8908

SOURCE Genzeon